The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Coral Laboratories Ltd

Coral Laboratories Ltd

BSE 524506 · NSE CORALAB · ISIN INE683E01017 · Group XT · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹638.25

-1.05%

BSE close, 28 August 2026

Market cap

₹228.02 cr

0.4 cr shares · Micro cap

Free float

₹58.94 cr

as published

P/E · P/B

11.9× · 1.12×

EPS ₹53.76 · BV ₹569.87

FY25-26 rev / PAT

85.90 / 16.38

₹ cr, as filed

Filings, window

17

3 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹360.00 52-WK HIGH ₹679.00 ₹638.25 87% of range
Against 52-week high-6.0%
Against 52-week low+77.3%
Day change-1.05%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹53.76
Price / earnings11.87×
Price / book1.12×
Book value — derived, price ÷ P/B₹569.87
Return on equity9.44%
Operating margin25.78%
Net margin18.19%

Consistency check

P/B ÷ P/E, which must equal ROE
9.44%
ROE as published
9.44%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 29.62 5.39 15.08 25.78% 18.19%
Mar-26 · Q 26.48 5.22 14.62 33.38% 19.73%
FY25-26 85.90 16.38 45.85 29.60% 19.07%

Quarter on quarter

Revenue, quarter on quarter
+11.9%
Net profit, quarter on quarter
+3.3%
Operating margin, quarter on quarter
-760 bps

Disclosure profile 17 filings in the window

0 median 17.0 p75 · 25 sector max 52 17 51th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome2
Results1
Selected sub-total3
Procedural
AGM / EGM4
Board Meeting2
Newspaper Publication2
Postal Ballot2
Annual Report1
Book Closure1
Record Date1
Trading Window1
Procedural sub-total14
Total17

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

17 filings · 3 selected · busiest 2026-08-14

Filing rhythm · the twelve most recent

2026-08-142026-09-30

SelectedProcedural

Filings

17 in the window · 8 earlier on record

  1. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting Results and Scrutinizer Report for AGM held on September 30, 2026

    AGM/EGM / AGM View filing →

  2. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 44th Annual General Meeting of the Company held on Tuesday, 29th September 2026

    AGM/EGM / AGM View filing →

  3. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 25 September 2026 ·

    Board Outcome

    Board Meeting Outcome for Considered And Approved Cost Audit Report In CRA-3 For The Financial Year 2025-26

    Considered and approved Cost Audit Report in CRA-3 for the financial year 2025-26

    Board Meeting / Outcome of Board Meeting View filing →

  5. 21 September 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On September 25, 2026

    Coral Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 ,inter alia, to consider and approve Intimation of Board meeting ....

    Board Meeting / Board Meeting View filing →

  6. 4 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual report for the financial year 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  7. 4 September 2026 ·

    AGM / EGM

    Notice Of 44Th AGM Scheduled To Be Held On September 29, 2026

    Notice of 44th AGM scheduled to be held on September 29, 2026.

    AGM/EGM / AGM View filing →

  8. 3 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copy of News paper Publication

    Company Update / Newspaper Publication View filing →

  9. 14 August 2026 ·

    Book Closure

    Notice Of Book Closure

    Notice of Book Closure

    Corp. Action / Book Closure View filing →

  10. 14 August 2026 ·

    AGM / EGM

    Intimation For Holding 44Th AGM

    Intimation for holding 44th AGM

    AGM/EGM / AGM View filing →

  11. 14 August 2026 ·

    Results

    Financial Results For The Quarter Ended On June 30, 2026

    Financial results for the quarter ended on June 30, 2026

    Result / Financial Results View filing →

  12. 14 August 2026 ·

    Record Date

    Notice Of Book Closure And Record Date

    Record date for final dividend and Book Closure date

    Corp. Action / Record Date View filing →

  13. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board meeting

    Board Meeting / Outcome of Board Meeting View filing →

  14. 6 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication on shares to be transferred to IEPF

    Company Update / Newspaper Publication View filing →

  15. 5 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting

    Coral Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Standalone unaudited ....

    Board Meeting / Board Meeting View filing →

  16. 23 July 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Postal ballot e-voting results alongwith Scrutinizer's Report

    AGM/EGM / Postal Ballot View filing →

  17. 23 July 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Outcome of Postal ballot result alongwith Scrutinizer Report

    AGM/EGM / Postal Ballot View filing →

RSS feed for Coral Laboratories Ltd · the 50 most recent filings